HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Jacques Kiladjian Selected Research

anagrelide (Agrylin)

9/2021Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet.
1/2018Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study.
4/2014Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.
2/2014Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Jacques Kiladjian Research Topics

Disease

65Primary Myelofibrosis (Myelosclerosis)
04/2024 - 07/2009
49Neoplasms (Cancer)
03/2024 - 11/2010
33Polycythemia Vera
03/2024 - 01/2003
19Anemia
02/2024 - 02/2002
18Splenomegaly
01/2023 - 02/2011
14Thrombocytopenia (Thrombopenia)
04/2024 - 03/2012
14Essential Thrombocythemia
03/2024 - 06/2006
11Thrombosis (Thrombus)
01/2024 - 01/2003
7Polycythemia (Erythrocytosis)
01/2022 - 05/2011
6Leukemia
01/2024 - 01/2003
6Fatigue
11/2023 - 07/2013
6Thrombocytosis (Thrombocythemia)
04/2022 - 10/2012
5Infections
04/2024 - 12/2017
5Pruritus (Itching)
11/2023 - 07/2013
5Fibrosis (Cirrhosis)
11/2023 - 05/2009
5Hemorrhage
01/2022 - 01/2017
4Cytopenia
02/2024 - 06/2016
4Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 03/2008
4Headache (Headaches)
01/2021 - 01/2016
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 11/2010
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2011 - 02/2006
3COVID-19
04/2024 - 05/2023
3Pneumonia (Pneumonitis)
09/2023 - 05/2017
3Inflammation (Inflammations)
04/2021 - 09/2018
2Hemolysis
09/2022 - 01/2021
2Chronic Disease (Chronic Diseases)
09/2022 - 01/2021
2Injection Site Reaction
09/2022 - 01/2021
2Leukocytosis (Pleocytosis)
04/2022 - 08/2015
2Wernicke Encephalopathy (Wernicke's Encephalopathy)
01/2021 - 07/2017
2Diarrhea
01/2021 - 01/2016
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2020 - 09/2007
2Peripheral Nervous System Diseases (PNS Diseases)
02/2018 - 12/2017
2Sepsis (Septicemia)
02/2018 - 05/2017
2Lymphoma (Lymphomas)
01/2018 - 07/2013
2Heart Failure
05/2017 - 01/2013
2Fever (Fevers)
05/2017 - 07/2013
1Breakthrough Infections
03/2024
1Neuralgia (Stump Neuralgia)
11/2023
1Hyponatremia
11/2023
1Exanthema (Rash)
11/2023
1Melanoma (Melanoma, Malignant)
11/2023

Drug/Important Bio-Agent (IBA)

41ruxolitinibIBA
02/2024 - 03/2012
24Janus Kinase InhibitorsIBA
02/2024 - 12/2013
15N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
02/2024 - 12/2017
14InterferonsIBA
03/2024 - 09/2006
14Janus KinasesIBA
02/2024 - 03/2012
13Hydroxyurea (Hydrea)FDA LinkGeneric
07/2023 - 06/2006
911- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
04/2024 - 05/2017
9fedratinibIBA
01/2023 - 07/2017
9Proteins (Proteins, Gene)FDA Link
11/2022 - 12/2010
7Interferon-alpha (Interferon Alfa)IBA
09/2021 - 10/2008
6Syntex adjuvant formulationIBA
02/2024 - 11/2012
6Hemoglobins (Hemoglobin)IBA
01/2024 - 03/2011
6Janus Kinase 1IBA
11/2023 - 09/2015
6Phosphotransferases (Kinase)IBA
10/2021 - 05/2011
5Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2015
5Danazol (Azol)FDA LinkGeneric
11/2023 - 04/2021
5activin AIBA
11/2023 - 01/2023
4imetelstatIBA
12/2022 - 10/2021
4Telomerase (Telomerase Reverse Transcriptase)IBA
12/2022 - 01/2020
4Janus Kinase 2IBA
12/2021 - 01/2016
4CalreticulinIBA
12/2021 - 01/2017
4anagrelide (Agrylin)FDA LinkGeneric
09/2021 - 02/2014
3IronIBA
01/2023 - 01/2017
3ErythropoietinFDA Link
01/2022 - 02/2002
3Pipobroman (Vercyte)FDA Link
10/2011 - 01/2003
2VaccinesIBA
04/2024 - 01/2020
2BNT162 VaccineIBA
04/2024 - 03/2024
2CytokinesIBA
01/2024 - 01/2021
2Activin Receptors (Activin Receptor)IBA
10/2023 - 12/2020
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2023 - 12/2021
2LigandsIBA
12/2022 - 12/2020
2pegcetacoplanIBA
09/2022 - 01/2021
2eculizumabFDA Link
09/2022 - 01/2021
2NF-kappa B (NF-kB)IBA
01/2021 - 02/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2019 - 12/2018
2Immunologic Factors (Immunomodulators)IBA
06/2016 - 02/2011
2HematinicsIBA
01/2015 - 02/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2012 - 05/2011
2Reticulin (Reticular Fiber)IBA
01/2012 - 05/2009
2Dihydrotachysterol (AT 10)IBA
10/2011 - 01/2003
1Immunoglobulin G (IgG)IBA
04/2024
1Secretory Immunoglobulin A (SIgA)IBA
04/2024
1Immunoglobulin A (IgA)IBA
04/2024
12019-nCoV Vaccine mRNA-1273IBA
04/2024
1Messenger RNA (mRNA)IBA
04/2024
1mRNA VaccinesIBA
03/2024
1N-(2-cyanoethylene)urea (BA 1)IBA
03/2024
1COVID-19 VaccinesIBA
03/2024
1Interferon alpha-2 (Roferon-A)FDA Link
03/2024
1BilirubinIBA
11/2023
1naporafenibIBA
11/2023

Therapy/Procedure

56Therapeutics
03/2024 - 01/2003
5Drug Therapy (Chemotherapy)
04/2022 - 01/2003
3Transplantation
01/2021 - 01/2018
3Erythrocyte Transfusion
02/2018 - 01/2017
2Splenectomy
01/2021 - 02/2011
2Drug Tapering
02/2018 - 03/2012
2Stem Cell Transplantation
01/2018 - 01/2015
1Injections
04/2024